Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations

Journal: Nature Communications

Published: 2019-12-19

DOI: 10.1038/s41467-019-13708-y

Affiliations: 12

Authors: 24

Go to article
Institutions Share
National Cancer Center Research Institute (NCCRI), Japan 0.29
Department of Obstetrics and Gynecology, UTokyo, Japan 0.25
Cancer Institute, JFCR, Japan 0.08
Department of Obstetrics and Gynecology, Juntendo University, Japan 0.08
School of Medicine, Juntendo University, Japan 0.08
Department of Obstetrics and Gynecology, Nagoya University, Japan 0.08
Graduate School of Medicine, UTokyo, Japan 0.04
National Cancer Center Hospital, Japan 0.04
Department of Pathology, UTokyo, Japan 0.04

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER